True crime and corporate fraud have a weird grip on us, but few figures fascinate the public quite like Elizabeth Holmes. Years after Theranos collapsed and a federal prison sentence took her out of the spotlight, the disgraced biotech founder is back dominating cultural conversations. This time, a staggering wave of renewed interest is driving massive spikes in streaming numbers for past adaptations while selling out indie cinemas nationwide.
The immediate catalyst is You Can See Everything, a secretive documentary directed by Nathan Fielder and Lance Oppenheim. Produced by A24 and filmed largely in 2023 just before Holmes began her 11-year prison sentence, the project has completely upended box office expectations. Pulling in $15 million in North America across just 855 screens during its opening weekend, it scored the best documentary debut in over two decades. It even outpaced major studio releases, leaving industry analysts scrambling to explain why a story we already know backwards and forwards can still pull such massive crowds.
The Streaming Rebound Effect
When major pop culture touchstones hit theaters, audiences rarely limit their consumption to just one piece of media. They go down rabbit holes. Following the first teaser for You Can See Everything dropping in early September, viewership for The Dropout—Hulu's 2022 limited series starring Amanda Seyfried as Holmes—skyrocketed by 186% compared to the previous month.
Interest didn't peak there. As opening weekend approached in mid-October, weekly viewership figures for the dramatized series nearly doubled again, jumping another 92%. At the same time, John Carreyrou’s 2018 investigative book Bad Blood, which originally blew the whistle on the Silicon Valley blood-testing startup, climbed right back onto the New York Times bestseller list.
People aren't just consuming content about Holmes; they are cross-referencing dramatizations, journalism, and raw documentary footage to piece together how a college dropout convinced powerful politicians, billionaires, and board members that a tiny box could revolutionize healthcare.
Why We Can't Look Away From Theranos
The enduring fascination with Theranos isn't just about corporate corruption. It's about human psychology and the absolute audacity of the lie. Holmes didn't just build a fraudulent business; she constructed an entire persona, right down to the deliberate black turtleneck and the famously altered baritone voice.
When you watch The Dropout or read about the trial, you see a masterclass in social engineering. Investors wanted to believe in a young, self-made female tech visionary so badly that basic technical scrutiny flew out the window. That corporate blind spot hits close to home. It shows how easily institutions can be charmed by confidence and marketing buzzwords over hard data.
Now, with You Can See Everything pushing boundaries—earning whispers of historic Oscar nominations for best picture and an awards campaign for Seyfried's supporting role recognition—the cultural footprint of the Theranos scandal expands even further.
If you want to understand why this story still commands your attention, stop treating it as a distant news story. It's a modern morality tale about the dangers of unchecked hype. Dive back into the source material, reexamine the investigations, and look closely at how easily an entire industry bought into an impossible promise.
